Linda Mindeholm

Title: Linda Mindeholm: Innovator in Pharmaceutical Compositions

Introduction

Linda Mindeholm is a prominent inventor based in Bettlach, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of human growth hormone (hGH) formulations. Her innovative work focuses on enhancing the delivery of hGH through oral administration, which has important implications for treating growth hormone deficiencies.

Latest Patents

Linda Mindeholm holds 1 patent for her invention titled "Pharmaceutical compositions comprising hGH for oral delivery." This patent describes dosage forms of human growth hormone that utilize an absorption enhancer to facilitate the hormone's entry into the systemic circulation in a biologically active form. The invention is particularly relevant for patients requiring oral administration of hGH, providing a new avenue for treatment of related deficiencies and disorders.

Career Highlights

Throughout her career, Linda has been associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to collaborate with some of the brightest minds in the industry, contributing to advancements in pharmaceutical science.

Collaborations

Linda Mindeholm has worked alongside notable colleagues such as Moise Azria and Yatindra Joshi. Their collaborative efforts have furthered the development of innovative solutions in the pharmaceutical sector.

Conclusion

Linda Mindeholm's contributions to the field of pharmaceutical compositions, particularly in the area of human growth hormone delivery, highlight her role as a key innovator. Her work not only advances medical science but also improves the quality of life for patients with growth hormone deficiencies.